Apolipoproteins, the protein components of lipoproteins that transport lipids through the bloodstream, have emerged as critical biomarkers for cardiovascular disease risk assessment and metabolic disorder diagnosis. The global apolipoprotein testing market, valued at USD 3.11-3.62 billion in 2024-2025, is projected to reach USD 4.228-5.3392 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.6-5.7%​ . This comprehensive guide provides an in-depth analysis of the global buyer landscape, identifying key purchasing organizations across clinical diagnostics, research institutions, and healthcare facilities that procure apolipoprotein testing kits, antibodies, calibrators, and related products. 1. Market Overview: Size, Segmentation, and Growth Drivers 1.1 Market Size and Projections The apolipoprotein testing and research…